The European\u00a0PV\u00a0device market will grow\u00a0modestly\u00a0over the forecast period, driven by increasing adoption of drug-eluting products as more clinical evidence for these technologies emerges, rising procedure volumes for iliac and lower limb indications, and the increasing adoption of endovascular techniques over surgical intervention. However, revenue growth will be limited to some extent by increasing price competition and ongoing cost constraints coupled with unfavorable reimbursement policies.<\/p>\n
This Medtech 360 Report provides high-level market metrics for\u00a0PV\u00a0devices in Europe, including country-level\u00a0data for major countries and aggregate data for the rest of the\u00a0Europe from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-571892","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-europe","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/571892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/571892\/revisions"}],"predecessor-version":[{"id":572125,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/571892\/revisions\/572125"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=571892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}